Delivery Order SPE2DB22D3004-SPE2DB25FRB73
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,388.95 to AmerisourceBergen Drug Corp for Apretude ER 600 mg/3 ml vials on October 17, 2025, with completion expected by November 7, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $2,388.96 to AmerisourceBergen Drug Corp for the supply of Apretude ER 600 mg/3 mL vials on September 25, 2025, with an ultimate completion date of October 17, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $45,142.44 to AmerisourceBergen Drug Corp on June 6, 2025, with an ultimate completion date of June 9, 2025. This firm fixed-price, non-set-aside contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contractor, headquartered in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,913.99 to AmerisourceBergen Drug Corp on July 31, 2025, with a completion date of the same day. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $38,238.54 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a non-competitive award and constitutes a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $82,029.40 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $84,674.22 to AmerisourceBergen Drug Corp on September 29, 2025, for pharmaceutical and medical supply delivery. The non-competitive, firm fixed-price delivery order is set to conclude on September 30, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,278.31 on July 28, 2025, by the Defense Logistics Agency's Medical Supply Chain with a completion date of July 29, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $18,890 to AmerisourceBergen Drug Corp on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999 through December 2026. The award carries no set-aside designation and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $40,181.69 to AmerisourceBergen Drug Corp on August 27, 2025, with completion scheduled for August 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.9 million through December 2026. The delivery order will be fulfilled from...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRB73Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of Apretude ER 600 mg/3 mL vials. This firm fixed-price delivery order, valued at $2,388.96, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle designated SPE2DX and active through December 2026. The award was made through open competition with no set-aside designation. Performance will be completed by July 8, 2025, with the product to be supplied from AmerisourceBergen's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare procurement, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's established relationship with DLA through the SPE2DX IDC enables it to fulfill varied federal medical supply requirements while supporting military healthcare programs globally, with service extending to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 6/13/25 |